机构:[1]Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and visual Sciences, National Engineering Research Center for Ophthalmology. Beijing, China.研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Department of Ophthalmology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital. Nanjing, China.江苏省人民医院[3]Advanced Ophthalmology Laboratory (AOL), Robotrak Technologies, Nanjing, China.[4]Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
To investigate the temporal sequence of changes in the photoreceptor cell mosaic in patients with Stargardt disease type 1 (STGD1), using adaptive optics scanning laser ophthalmoscopy (AOSLO).Two brothers with genetically confirmed STGD1 underwent comprehensive eye exams, spectral-domain optical coherence tomography (SD-OCT), fundus auto fluorescence (FAF) and AOSLO imaging 3 times over the course of 28 months. Confocal images of the cones and rods were obtained from the central fovea to 10 degrees inferiorly. Photoreceptors were counted in sampling windows at 100 µm intervals of 200 µm × 200 µm for cones and 50 µm × 50 µm for rods, using custom cell marking software with manual correction. Photoreceptor density and spacing were measured and compared across imaging sessions using one-way ANOVA.AOSLO revealed the younger brother had a 30% decline in foveal cone density after 8 months, followed by complete loss of foveal cones at 28 months; the older brother had no detectable foveal cones at baseline. In the peripheral macula, cone and rod spacings were greater than normal in both patients. The ratio of the cone spacing to rod spacing was greater than normal across all eccentricities, with a greater divergence closer to the foveal center.Cone cell loss may be an early pathogenetic step in Stargardt disease. AOSLO provides the capability to track individual photoreceptor changes longitudinally in Stargardt disease.The pathogenetic mechanism of Stargardt disease remains poorly understood. We used high resolution AOSLO to track the progression of the disease and found cone cell loss may be an early pathogenetic step in Stargardt disease.
基金:
This work was supported by National Institutes of Health (NIH)
grants EY021786, EY014375, and EY001319; a grant from the Edward N. & Della L.
Thome Memorial Foundation; University of Rochester Clinical Trials and Science
Institute award number UL1 RR024160 from the National Center for Research
Resources and the National Center for Advancing Translational Sciences of the NIH;
an unrestricted departmental grant from Research to Prevent Blindness; and the
capital health research and development of special (No. 2022-1G-4083)
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and visual Sciences, National Engineering Research Center for Ophthalmology. Beijing, China.[*1]#1 Dong Jiao Min Xiang, Beijing 100730, China
通讯作者:
通讯机构:[1]Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and visual Sciences, National Engineering Research Center for Ophthalmology. Beijing, China.[*1]#1 Dong Jiao Min Xiang, Beijing 100730, China
推荐引用方式(GB/T 7714):
Song Hongxin,Hang Hui,Li Kaiwen,et al.Longitudinal Adaptive Optics Scanning Laser Ophthalmoscopy Reveals Regional Variation in Cone and Rod Photoreceptor Loss in Stargardt Disease[J].Retina (Philadelphia, Pa.).2024,44(8):1403-1412.doi:10.1097/IAE.0000000000004104.
APA:
Song Hongxin,Hang Hui,Li Kaiwen,Rossi Ethan A&Zhang Jie.(2024).Longitudinal Adaptive Optics Scanning Laser Ophthalmoscopy Reveals Regional Variation in Cone and Rod Photoreceptor Loss in Stargardt Disease.Retina (Philadelphia, Pa.),44,(8)
MLA:
Song Hongxin,et al."Longitudinal Adaptive Optics Scanning Laser Ophthalmoscopy Reveals Regional Variation in Cone and Rod Photoreceptor Loss in Stargardt Disease".Retina (Philadelphia, Pa.) 44..8(2024):1403-1412